Latest News 2021: All information related to the latest news alerts in the SFVSl News 2021 portal is now being made available in English language, so that you will get the first news updates of all business and car-bikes in India.
All news related to country, world, entertainment, sports, business, and politics. Find all the latest English news, breaking news at Shortfilmvideostatus.com.
यह खबर नवभारत टाइम्स की ओर से आई है
[ad_1]
Highlights:
- This cocktail contains two types of drugs Casrivimab and Imdevimab.
- Anti-bodies start to form inside the patient as soon as you give this cocktail
- 84-year-old Mohabbat Singh is admitted in Medanta of Gurugram, this dose given to him
The drug that was given to former US President Donald Trump after being corona, has now been entered in India as well. This cocktail of medicine was given to India's first Corona patient. The patient is 84-year-old Mohabbat Singh of Haryana, admitted in Medanta, Gurugram. Singh, who has been undergoing treatment for the last five days, was given medication for 30 minutes.
The drug, Regeneron, is known to be a successful treatment for some patients. This drug shortens the symptom duration and also reduces the viral load by rapidly creating antibodies.
'It is different from plasma therapy.
Dr. Naresh Trehan, director of Medanta, said that the first batch of Roche drug with two antibodies Kasirivimab and Imdevimab reached India on Monday. This drug is different from corona-correcting plasma and completely different from drugs such as remadecivir or tocilizumab.
'80% of patients do not need to be hospitalized'
Studies show that 80 percent of patients taking this drug did not require hospitalization and this reduced the duration of symptoms in addition to reducing mortality.
'Treatment with just one dose'
When Trump became Corona virus positive last year, a monoclonal antibody cocktail was used in his treatment. Within a week, he was back at work. Cipla is marketing the drug in hospitals at an estimated price of Rs 59,000 per dose. Only one dose is needed for treatment.
Antibodies begin to develop immediately
In any covid patient, normal antibodies develop only 14 days after infection. But in this drug, lab-made antibodies work immediately.
Dr. Naresh said that the government has imposed the only condition on the use of this drug that it should be used in patients above 65 with comradities and immunocompromised. Even people above 55 who have heart related disease can be given this medicine.
File photo
[ad_2]
Social Plugin